Article
Resection of renal metastases to the pancreas: a surgical challenge.
Department of Surgery, Hammersmith Hospital, London, UK.
HPB (impact factor:
1.6).
02/2003;
5(3):137-41.
DOI:10.1080/13651820310000677
pp.137-41
Source: PubMed
- Citations (1)
-
Cited In (0)
-
Article: Management of the pancreatic metastases from renal cell carcinoma: report of four resected cases.
[show abstract] [hide abstract]
ABSTRACT: The pancreas is an uncommon site for metastasis from renal cell carcinoma. In most cases, pancreatic metastases occur as part of widespread nodal and visceral involvement, and there is thus evidence of metastatic disease elsewhere in the body. We present 4 cases with resectable pancreatic metastases arising from renal cell tumors without involvement of the regional lymph nodes at the operation. Three cases out of 4 were asymptomatic and the pancreatic metastases were detected by routine follow-up examination of renal cell carcinoma. Aggressive surgical treatment for the solitary metastatic lesion is advocated. Spread of renal cell carcinoma to the pancreas is, however, via the hematogenous route, and even solitary pancreatic metastasis may be one of the manifestations of the systemic metastasis of renal cell carcinoma. No pancreatic regional lymph nodes metastases were noted. Pancreatectomy should be undertaken to remove the tumor with adequate resection margins while preserving as much of the gland as possible. The prognosis of pancreatic metastases arising from a renal cell carcinoma is discussed with a review of the literature. Adjuvant chemo- and endocrine therapy should also be considered in these cases.Hepato-gastroenterology 45(22):1150-4. · 0.66 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
2 years
4 years
9 years
Dynamic spiral CT
follow-up imaging
irresectable disease
long-term survival
metastatic RCC
mild abdominal pain
multiple RCC metastases
pancreatic adenocarcinoma
pancreatic resection
pancreatic tumour
Patients present
rare event
resectable disease
surgical resection
vascularised tumour
weight loss
widespread disease